GENE ONLINE|News &
ASCO
ASCO 2020: AstraZeneca and Daiichi Sankyo’s Enhertu Impresses with Benefits in Lung, Stomach and Colorectal Cancer Trials
2020-06-05
ASCO 2020: Keytruda Shines as New Quality of Care in Treating metastatic Colorectal Cancer
2020-06-03
ASCO 2020: Genentech’s Novel anti-TIGIT Therapy Shows Promise in Phase II Lung Cancer Trials
2020-05-31
ASCO 2020: Global Consortiums CCC19, and TERAVOLT Improve Understanding of Cancer and COVID-19
2020-05-31
ASCO 2020: AZ’s Tagrisso Promises Disease-Free Survival in Postoperative EGFR Mutation-Positive NSCLC
2020-05-30
ASCO 2020: Results from the INFORM Registry, A Step Towards Personalized Therapy in Pediatric Cancer
2020-05-29
ASCO 2020: Maintenance Therapy with Avelumab Post-Chemo Improves Overall Survival of Bladder Cancer Patients
2020-05-29
Novartis’ Kisqali Shows Promising Results in Advanced Breast Cancer Patients with Liver Metastases
2020-05-28
Amgen’s Efficacy of AMG 510 to KRAS G12C Mutant Critical for Future Directions and Business Investments
2019-10-02
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
